BASILIXIMAB

BASILIXIMAB was reported 11930 times

BASILIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ARGENTINE HAEMORRHAGIC FEVER 9 1.0000
1 DIABETIC MACROANGIOPATHY 15 0.4545
2 VENTRICULAR REMODELLING 28 0.3889
3 PASSENGER LYMPHOCYTE SYNDROME 20 0.3279
4 INTESTINE TRANSPLANT REJECTION 28 0.2917
5 PARVOVIRUS B19 INFECTION REACTIVATION 9 0.2812
6 DELAYED GRAFT FUNCTION 192 0.2700
7 RENAL GRAFT LOSS 20 0.2469
8 ENCEPHALITIS PROTOZOAL 13 0.2321
9 RENAL LYMPHOCELE 10 0.2174
10 ARTERITIS INFECTIVE 13 0.2131
11 INTRACRANIAL INFECTION 26 0.2080
12 RENAL GRAFT INFECTION 43 0.1853
13 COMPLICATIONS OF TRANSPLANTED LUNG 56 0.1824
14 URETERAL NECROSIS 11 0.1774
15 RENAL ADENOMA 9 0.1765
16 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 395 0.1684
17 KIDNEY TRANSPLANT REJECTION 786 0.1636
18 MASTITIS BACTERIAL 10 0.1562
19 COMPLICATIONS OF TRANSPLANTED KIDNEY 354 0.1559
20 URINARY FISTULA 18 0.1500
21 ADENOVIRUS INTERSTITIAL NEPHRITIS 8 0.1429
22 RHODOCOCCUS INFECTION 23 0.1386
23 CHRONIC ALLOGRAFT NEPHROPATHY 108 0.1379
24 BILOMA 19 0.1348
25 PARVOVIRUS B19 INFECTION 120 0.1341
26 CEREBRAL VENTRICLE COLLAPSE 10 0.1333
27 CHORIOMENINGITIS LYMPHOCYTIC 9 0.1304
28 DONOR SPECIFIC ANTIBODY PRESENT 20 0.1299
29 PANCREAS TRANSPLANT REJECTION 26 0.1294
30 UREAPLASMA INFECTION 51 0.1250
31 HERPES SIMPLEX HEPATITIS 30 0.1250
32 CUTANEOUS MUCORMYCOSIS 21 0.1141
33 TRANSPLANT REJECTION 874 0.1090
34 CAPILLARITIS 30 0.1087
35 LYMPHOCELE 70 0.1054
36 MICROSPORIDIA INFECTION 37 0.1054
37 HUMAN EHRLICHIOSIS 22 0.1053
38 POLYOMAVIRUS VIRAEMIA 110 0.1036
39 VIRAL VASCULITIS 11 0.1028
40 HUMAN HERPESVIRUS 8 INFECTION 60 0.0985
41 OEDEMATOUS KIDNEY 25 0.0943
42 HEPATIC ARTERY STENOSIS 12 0.0923
43 BK VIRUS INFECTION 310 0.0918
44 MALACOPLAKIA 42 0.0917
45 MYCOTIC ENDOPHTHALMITIS 17 0.0899
46 TRANSPLANT DYSFUNCTION 159 0.0890
47 GRAFT THROMBOSIS 23 0.0881
48 RENAL CORTICAL NECROSIS 20 0.0858
49 GENITAL HERPES SIMPLEX 18 0.0849
50 CYTOMEGALOVIRUS SYNDROME 14 0.0848
51 RENAL TUBULAR ATROPHY 74 0.0839
52 RENAL TRANSPLANT FAILURE 81 0.0820
53 CYTOMEGALOVIRUS ANTIGEN POSITIVE 15 0.0820
54 DISSEMINATED MUCORMYCOSIS 32 0.0812
55 GRAFT DYSFUNCTION 23 0.0807
56 MYCOBACTERIUM HAEMOPHILUM INFECTION 23 0.0804
57 HERPES SIMPLEX VIRAEMIA 10 0.0800
58 CEREBRAL ASPERGILLOSIS 49 0.0797
59 RENAL ARTERIOSCLEROSIS 19 0.0779
60 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 123 0.0767
61 URINOMA 12 0.0759
62 ACID BASE BALANCE ABNORMAL 17 0.0759
63 SCEDOSPORIUM INFECTION 52 0.0737
64 MUCORMYCOSIS 189 0.0727
65 GASTROINTESTINAL MUCORMYCOSIS 12 0.0719
66 HERPES SIMPLEX PNEUMONIA 9 0.0709
67 STRONGYLOIDIASIS 114 0.0705
68 DISSEMINATED BLASTOMYCOSIS 12 0.0702
69 GRAFT LOSS 50 0.0690
70 TOOTH HYPOPLASIA 12 0.0690
71 URETERIC STENOSIS 54 0.0674
72 CYTOMEGALOVIRUS VIRAEMIA 293 0.0658
73 DISSEMINATED ASPERGILLOSIS 31 0.0657
74 LIVER TRANSPLANT REJECTION 117 0.0651
75 LYMPHORRHOEA 10 0.0641
76 POST TRANSPLANT DISTAL LIMB SYNDROME 13 0.0640
77 NEW ONSET DIABETES AFTER TRANSPLANTATION 11 0.0636
78 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 9 0.0629
79 PERINEPHRIC COLLECTION 9 0.0629
80 ADENOVIRAL HAEMORRHAGIC CYSTITIS 13 0.0622
81 COMPLICATIONS OF TRANSPLANTED LIVER 22 0.0609
82 TRICHODYSPLASIA SPINULOSA 23 0.0604
83 SMOOTH MUSCLE CELL NEOPLASM 25 0.0598
84 CYTOMEGALOVIRUS GASTRITIS 15 0.0593
85 LUNG TRANSPLANT REJECTION 39 0.0591
86 EPSTEIN-BARR VIRAEMIA 65 0.0586
87 INFECTIVE ANEURYSM 29 0.0586
88 GLOMERULOSCLEROSIS 37 0.0585
89 PARASPINAL ABSCESS 9 0.0581
90 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 17 0.0570
91 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 13 0.0565
92 GRAFT COMPLICATION 33 0.0562
93 KIDNEY FIBROSIS 97 0.0559
94 CYTOMEGALOVIRUS INFECTION 929 0.0558
95 PANCREATITIS HAEMORRHAGIC 26 0.0558
96 PERIRENAL HAEMATOMA 12 0.0553
97 KIDNEY RUPTURE 10 0.0538
98 INCISION SITE PAIN 63 0.0536
99 VIRAEMIA 74 0.0534
100 MYCOPLASMA INFECTION 41 0.0525
101 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 173 0.0523
102 RENAL VESSEL DISORDER 11 0.0521
103 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 263 0.0516
104 BRONCHIOLITIS OBLITERANS SYNDROME 9 0.0514
105 CYTOMEGALOVIRUS GASTROENTERITIS 11 0.0512
106 PULMONARY NOCARDIOSIS 40 0.0485
107 PULMONARY MUCORMYCOSIS 25 0.0473
108 RENAL TUBULAR INJURY 57 0.0469
109 MEDIASTINITIS 27 0.0466
110 ABDOMINAL WALL ABSCESS 30 0.0463
111 RENAL NECROSIS 10 0.0459
112 THROMBOTIC MICROANGIOPATHY 447 0.0458
113 RED BLOOD CELLS URINE POSITIVE 44 0.0455
114 RENAL AMYLOIDOSIS 11 0.0449
115 PANCREATIC ABSCESS 9 0.0446
116 TRANSPLANT FAILURE 107 0.0436
117 CYTOMEGALOVIRUS COLITIS 99 0.0430
118 GLOMERULONEPHROPATHY 11 0.0430
119 GEOTRICHUM INFECTION 9 0.0427
120 CYTOMEGALOVIRUS HEPATITIS 15 0.0424
121 AEROMONAS INFECTION 8 0.0423
122 PNEUMONIA CYTOMEGALOVIRAL 79 0.0406
123 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 14 0.0399
124 TRICHOSPORON INFECTION 16 0.0395
125 JC VIRUS INFECTION 63 0.0394
126 VIRAL HAEMORRHAGIC CYSTITIS 28 0.0393
127 SPHINCTER OF ODDI DYSFUNCTION 16 0.0388
128 RENAL HAEMATOMA 20 0.0388
129 RENAL ARTERY THROMBOSIS 12 0.0388
130 ENAMEL ANOMALY 11 0.0385
131 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 46 0.0383
132 AMOEBIASIS 9 0.0383
133 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 31 0.0381
134 SYSTEMIC MYCOSIS 44 0.0377
135 ALTERNARIA INFECTION 14 0.0376
136 CHOLANGITIS INFECTIVE 10 0.0376
137 HEPATIC ARTERY THROMBOSIS 11 0.0375
138 AMERICAN TRYPANOSOMIASIS 10 0.0370
139 SARCOPENIA 16 0.0370
140 HUMAN POLYOMAVIRUS INFECTION 19 0.0358
141 RENAL VEIN THROMBOSIS 24 0.0355
142 CYTOMEGALOVIRUS TEST POSITIVE 62 0.0348
143 PERIOSTITIS 15 0.0347
144 HEART TRANSPLANT REJECTION 36 0.0347
145 PARVOVIRUS INFECTION 14 0.0347
146 FUSARIUM INFECTION 24 0.0343
147 ASPERGILLUS INFECTION 225 0.0342
148 TRANSIENT ACANTHOLYTIC DERMATOSIS 10 0.0340
149 ADENOVIRUS INFECTION 98 0.0338
150 CYTOMEGALOVIRUS INFECTION REACTIVATION 148 0.0335
151 ENTEROCOCCAL INFECTION 161 0.0333
152 EPSTEIN-BARR VIRUS INFECTION 205 0.0328
153 BACTERIAL PYELONEPHRITIS 11 0.0327
154 URETERIC DILATATION 9 0.0326
155 CRYPTOCOCCOSIS 53 0.0325
156 GRAFT INFECTION 11 0.0324
157 CRYPTOSPORIDIOSIS INFECTION 17 0.0324
158 OEDEMATOUS PANCREATITIS 18 0.0321
159 HUMAN HERPESVIRUS 6 ENCEPHALITIS 9 0.0317
160 STENOTROPHOMONAS INFECTION 43 0.0317
161 BLADDER HYPERTROPHY 14 0.0316
162 INFECTION REACTIVATION 36 0.0314
163 GASTROENTERITIS ESCHERICHIA COLI 17 0.0311
164 BLASTOMYCOSIS 15 0.0308
165 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 16 0.0305
166 ENTEROBACTER INFECTION 51 0.0303
167 RESPIRATORY TRACT INFECTION FUNGAL 16 0.0303
168 COMPLICATIONS OF TRANSPLANT SURGERY 15 0.0298
169 HAEMOLYTIC URAEMIC SYNDROME 69 0.0297
170 ENCEPHALITIS CYTOMEGALOVIRUS 13 0.0297
171 DIFFUSE ALVEOLAR DAMAGE 34 0.0296
172 MYCOBACTERIUM ABSCESSUS INFECTION 21 0.0294
173 GLOMERULONEPHRITIS 71 0.0290
174 LEIOMYOSARCOMA 11 0.0286
175 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 40 0.0283
176 GRAFT VERSUS HOST DISEASE 203 0.0282
177 HERPES SIMPLEX ENCEPHALITIS 13 0.0280
178 URINARY TRACT INFECTION ENTEROCOCCAL 26 0.0278
179 RENAL TUBULAR NECROSIS 268 0.0273
180 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 16 0.0271
181 PNEUMONIA NECROTISING 17 0.0263
182 PERICARDITIS CONSTRICTIVE 11 0.0261
183 CITROBACTER INFECTION 11 0.0256
184 HUMAN HERPESVIRUS 6 INFECTION 48 0.0254
185 HEPATIC HAEMATOMA 12 0.0253
186 HEPATITIS E 40 0.0253
187 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 53 0.0249
188 LYMPHOCYTIC INFILTRATION 25 0.0248
189 CARDIAC VALVE VEGETATION 12 0.0247
190 CYTOMEGALOVIRUS ENTEROCOLITIS 19 0.0247
191 CLEAR CELL RENAL CELL CARCINOMA 17 0.0244
192 CORYNEBACTERIUM INFECTION 13 0.0243
193 GRAFT VERSUS HOST DISEASE IN SKIN 53 0.0240
194 BRONCHOPULMONARY ASPERGILLOSIS 185 0.0238
195 DISSEMINATED CRYPTOCOCCOSIS 18 0.0238
196 HERPES ZOSTER DISSEMINATED 19 0.0237
197 ABDOMINAL COMPARTMENT SYNDROME 15 0.0235
198 NEPHROSCLEROSIS 26 0.0234
199 INFECTIOUS PLEURAL EFFUSION 35 0.0230
200 PHAEOHYPHOMYCOSIS 11 0.0230
201 WEST NILE VIRAL INFECTION 17 0.0227
202 EROSIVE DUODENITIS 18 0.0225
203 RENAL ARTERY STENOSIS 31 0.0225
204 BLINDNESS CORTICAL 11 0.0224
205 PNEUMONIA CRYPTOCOCCAL 21 0.0222
206 KAPOSI'S SARCOMA 11 0.0219
207 KLEBSIELLA INFECTION 110 0.0217
208 LOCKED-IN SYNDROME 10 0.0217
209 OSMOTIC DEMYELINATION SYNDROME 16 0.0217
210 TRANSPLANTATION COMPLICATION 9 0.0214
211 NOCARDIOSIS 54 0.0211
212 PSEUDOMONAL BACTERAEMIA 18 0.0211
213 ACINETOBACTER INFECTION 23 0.0210
214 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 58 0.0210
215 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 15 0.0209
216 ENTEROVIRUS INFECTION 18 0.0208
217 FUNGAEMIA 31 0.0197
218 NEPHROPATHY TOXIC 221 0.0197
219 DISSEMINATED TUBERCULOSIS 50 0.0195
220 RESPIRATORY TRACT INFLAMMATION 9 0.0193
221 PSEUDOMONAS INFECTION 164 0.0191
222 ARTERITIS 12 0.0190
223 HYPERAMMONAEMIA 95 0.0190
224 PELVIC FLUID COLLECTION 13 0.0184
225 HYPERAMYLASAEMIA 10 0.0183
226 IGA NEPHROPATHY 30 0.0181
227 ILEAL ULCER 18 0.0178
228 SPLENIC HAEMORRHAGE 9 0.0177
229 CENTRAL NERVOUS SYSTEM VASCULITIS 9 0.0176
230 GASTROINTESTINAL EROSION 11 0.0174
231 DRUG LEVEL FLUCTUATING 15 0.0169
232 ACUTE GRAFT VERSUS HOST DISEASE 77 0.0168
233 GRAFT VERSUS HOST DISEASE IN LIVER 12 0.0168
234 PNEUMOCYSTIS JIROVECII INFECTION 20 0.0167
235 SYSTEMIC CANDIDA 42 0.0167
236 BILE DUCT STENOSIS 20 0.0167
237 HYPERPLASIA 15 0.0167
238 GASTROENTERITIS NOROVIRUS 22 0.0166
239 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 29 0.0164
240 RENAL TUBULAR DISORDER 46 0.0163
241 HAPTOGLOBIN DECREASED 13 0.0161
242 CEREBRAL TOXOPLASMOSIS 15 0.0161
243 ENTEROCOCCAL BACTERAEMIA 17 0.0160
244 VARICELLA ZOSTER VIRUS INFECTION 33 0.0159
245 BRAIN ABSCESS 40 0.0158
246 TOXOPLASMOSIS 17 0.0157
247 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 150 0.0157
248 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 31 0.0157
249 ARTERIAL RUPTURE 12 0.0156
250 MULTIPLE ORGAN DYSFUNCTION SYNDROME 439 0.0155
251 CYTOMEGALOVIRUS CHORIORETINITIS 30 0.0154
252 HEPATITIS A 13 0.0153
253 ASPERGILLOSIS 20 0.0153
254 PNEUMONIA KLEBSIELLA 28 0.0152
255 HYDRONEPHROSIS 114 0.0152
256 DISTRIBUTIVE SHOCK 34 0.0150
257 ORCHITIS 16 0.0149
258 ESCHERICHIA INFECTION 122 0.0148
259 APLASIA PURE RED CELL 51 0.0148
260 ENCEPHALITIS VIRAL 18 0.0148
261 KLEBSIELLA BACTERAEMIA 14 0.0147
262 RENAL HAEMORRHAGE 30 0.0147
263 HERPES SIMPLEX 95 0.0146
264 CANDIDA SEPSIS 13 0.0145
265 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 19 0.0144
266 GASTROINTESTINAL VIRAL INFECTION 15 0.0144
267 ESCHERICHIA URINARY TRACT INFECTION 61 0.0143
268 KLEBSIELLA SEPSIS 16 0.0142
269 CYSTITIS HAEMORRHAGIC 57 0.0141
270 ENDOCARDITIS BACTERIAL 11 0.0140
271 MICROANGIOPATHY 13 0.0138
272 PNEUMOCYSTIS JIROVECII PNEUMONIA 138 0.0137
273 PNEUMONIA PSEUDOMONAL 21 0.0137
274 ACUTE LUNG INJURY 16 0.0135
275 RENAL ABSCESS 11 0.0134
276 SMALL INTESTINAL PERFORATION 25 0.0133
277 PYELONEPHRITIS ACUTE 26 0.0132
278 SUBCUTANEOUS EMPHYSEMA 13 0.0132
279 FUNGAL SEPSIS 11 0.0132
280 CENTRAL NERVOUS SYSTEM INFECTION 15 0.0131
281 PNEUMOCYSTIS JIROVECI PNEUMONIA 29 0.0130
282 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0130
283 OBLITERATIVE BRONCHIOLITIS 17 0.0129
284 INTRA-ABDOMINAL HAEMATOMA 16 0.0129
285 RENAL CELL CARCINOMA 63 0.0129
286 NEPHRECTOMY 19 0.0128
287 ANURIA 110 0.0128
288 CRYOGLOBULINAEMIA 9 0.0126
289 ESCHAR 9 0.0123
290 NEUROENDOCRINE CARCINOMA OF THE SKIN 12 0.0123
291 CHRONIC GRAFT VERSUS HOST DISEASE 44 0.0122
292 PYURIA 12 0.0121
293 ATYPICAL MYCOBACTERIAL INFECTION 17 0.0120
294 URINE OUTPUT DECREASED 105 0.0120
295 STEROID DIABETES 18 0.0120
296 HYPERURICAEMIA 49 0.0119
297 RENAL INFARCT 17 0.0117
298 COCCIDIOIDOMYCOSIS 14 0.0117
299 TRANSITIONAL CELL CARCINOMA 15 0.0116
300 TUBULOINTERSTITIAL NEPHRITIS 215 0.0115
301 OLIGURIA 71 0.0114
302 ENTEROCOCCAL SEPSIS 9 0.0111
303 BACTERIAL SEPSIS 36 0.0110
304 PROTEIN URINE PRESENT 55 0.0110
305 MYCOBACTERIAL INFECTION 19 0.0110
306 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 82 0.0109
307 EXTREMITY NECROSIS 19 0.0109
308 VASOSPASM 10 0.0109
309 VANISHING BILE DUCT SYNDROME 12 0.0108
310 ESCHERICHIA BACTERAEMIA 25 0.0106
311 CERVICAL DYSPLASIA 23 0.0105
312 ABDOMINAL LYMPHADENOPATHY 9 0.0104
313 MENINGITIS CRYPTOCOCCAL 18 0.0103
314 URETERIC OBSTRUCTION 14 0.0103
315 INTESTINAL PSEUDO-OBSTRUCTION 9 0.0102
316 PNEUMONIA FUNGAL 40 0.0101
317 WOUND DEHISCENCE 34 0.0101
318 WOUND INFECTION STAPHYLOCOCCAL 17 0.0098
319 ABDOMINAL INFECTION 25 0.0098
320 PSEUDOMONAL SEPSIS 17 0.0097
321 FUNGAL SKIN INFECTION 39 0.0097
322 INTRA-ABDOMINAL HAEMORRHAGE 23 0.0096
323 SKIN NECROSIS 50 0.0096
324 HISTOPLASMOSIS 17 0.0096
325 HYPOPERFUSION 10 0.0095
326 NEUTROPHIL COUNT INCREASED 97 0.0095
327 INTERMITTENT CLAUDICATION 15 0.0095
328 ARTERIAL DISORDER 18 0.0094
329 ASTERIXIS 10 0.0094
330 PYELOCALIECTASIS 9 0.0094
331 ARTERIAL THROMBOSIS 18 0.0093
332 CAPILLARY LEAK SYNDROME 19 0.0092
333 URINARY TRACT INFECTION BACTERIAL 23 0.0091
334 LIVER ABSCESS 29 0.0089
335 CANDIDA INFECTION 148 0.0088
336 BACTERAEMIA 103 0.0087
337 NEPHROGENIC DIABETES INSIPIDUS 10 0.0087
338 SEROMA 11 0.0086
339 EPIDIDYMITIS 10 0.0086
340 PERIPHERAL ARTERY THROMBOSIS 12 0.0085
341 H1N1 INFLUENZA 12 0.0085
342 ACUTE RESPIRATORY DISTRESS SYNDROME 151 0.0085
343 HEPATIC NECROSIS 32 0.0085
344 PATHOGEN RESISTANCE 77 0.0084
345 DIFFUSE LARGE B-CELL LYMPHOMA 65 0.0084
346 PNEUMONIA INFLUENZAL 10 0.0084
347 PYELONEPHRITIS 71 0.0082
348 RIGHT VENTRICULAR DYSFUNCTION 9 0.0082
349 PNEUMONIA VIRAL 26 0.0081
350 DISSEMINATED INTRAVASCULAR COAGULATION 113 0.0080
351 BLOOD CREATININE INCREASED 522 0.0080
352 BILIARY TRACT DISORDER 11 0.0079
353 HAEMOTHORAX 23 0.0079
354 BRADYARRHYTHMIA 13 0.0079
355 MECHANICAL VENTILATION 15 0.0079
356 PAPILLOMA VIRAL INFECTION 13 0.0079
357 SQUAMOUS CELL CARCINOMA 74 0.0079
358 DENGUE FEVER 18 0.0078
359 GRANULOMA 27 0.0078
360 RENAL MASS 16 0.0078
361 MUCOSAL HAEMORRHAGE 9 0.0078
362 PROTEINURIA 147 0.0077
363 BILIRUBIN CONJUGATED INCREASED 18 0.0077
364 LEUKOPENIA 385 0.0077
365 PNEUMONIA BACTERIAL 70 0.0076
366 HISTOPLASMOSIS DISSEMINATED 12 0.0076
367 EMPYEMA 15 0.0075
368 GASTROINTESTINAL STROMAL TUMOUR 20 0.0075
369 LYMPHOPROLIFERATIVE DISORDER 22 0.0075
370 BILIARY DILATATION 11 0.0075
371 DYSLIPIDAEMIA 38 0.0075
372 HISTIOCYTOSIS HAEMATOPHAGIC 22 0.0074
373 NECROSIS 41 0.0074
374 B-CELL LYMPHOMA 25 0.0074
375 BLOOD UREA INCREASED 123 0.0073
376 HYPOGAMMAGLOBULINAEMIA 48 0.0073
377 LYMPHOCYTE COUNT DECREASED 129 0.0073
378 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 16 0.0073
379 ANTIBODY TEST POSITIVE 12 0.0072
380 GASTROINTESTINAL NECROSIS 21 0.0072
381 VARICELLA 17 0.0071
382 MENINGITIS BACTERIAL 10 0.0070
383 MULTI-ORGAN FAILURE 117 0.0068
384 INTESTINAL DILATATION 9 0.0067
385 LEUKOENCEPHALOPATHY 25 0.0067
386 HEPATITIS C 80 0.0066
387 METASTATIC MALIGNANT MELANOMA 15 0.0065
388 HEPATORENAL SYNDROME 11 0.0065
389 BACTERIAL INFECTION 121 0.0065
390 NEUROLOGICAL SYMPTOM 37 0.0065
391 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 53 0.0064
392 RENAL TUBULAR ACIDOSIS 14 0.0064
393 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 17 0.0064
394 FUNCTIONAL GASTROINTESTINAL DISORDER 22 0.0064
395 BRAIN HERNIATION 19 0.0064
396 RETROPERITONEAL HAEMATOMA 14 0.0063
397 BLOOD ALBUMIN DECREASED 50 0.0063
398 SEPTIC SHOCK 272 0.0062
399 DRUG RESISTANCE 160 0.0062
400 LYMPHOPENIA 88 0.0062
401 PULMONARY SEPSIS 9 0.0062
402 BRAIN NATRIURETIC PEPTIDE INCREASED 19 0.0062
403 CYTOPENIA 75 0.0061
404 PNEUMOMEDIASTINUM 11 0.0061
405 UROSEPSIS 56 0.0061
406 HAEMODYNAMIC INSTABILITY 46 0.0060
407 GUILLAIN-BARRE SYNDROME 29 0.0060
408 HEPATITIS CHOLESTATIC 36 0.0060
409 INTERVERTEBRAL DISCITIS 11 0.0058
410 HYPOPROTEINAEMIA 11 0.0058
411 RETINITIS 10 0.0058
412 NEPHROPATHY 54 0.0058
413 LIVER TRANSPLANT 21 0.0058
414 OESOPHAGEAL CANDIDIASIS 23 0.0058
415 HYPERAMMONAEMIC ENCEPHALOPATHY 10 0.0057
416 LUNG ABSCESS 12 0.0057
417 LUNG CONSOLIDATION 16 0.0057
418 IMPRISONMENT 10 0.0057
419 ACUTE MYELOID LEUKAEMIA RECURRENT 12 0.0056
420 PNEUMONIA STAPHYLOCOCCAL 11 0.0056
421 RENAL IMPAIRMENT 467 0.0056
422 AUTOIMMUNE HAEMOLYTIC ANAEMIA 19 0.0055
423 MONOPARESIS 10 0.0055
424 AZOTAEMIA 22 0.0055
425 CHOLANGITIS 34 0.0055
426 SPLENIC RUPTURE 9 0.0055
427 BLOOD CREATININE DECREASED 17 0.0054
428 RHINOVIRUS INFECTION 21 0.0054
429 PULMONARY ALVEOLAR HAEMORRHAGE 30 0.0053
430 POST PROCEDURAL HAEMATOMA 9 0.0053
431 DRUG LEVEL INCREASED 88 0.0053
432 CHRONIC GASTRITIS 12 0.0053
433 HEPATITIS B 32 0.0053
434 BRAIN OEDEMA 67 0.0053
435 BLOOD AMYLASE INCREASED 9 0.0053
436 HAEMODIALYSIS 44 0.0052
437 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 20 0.0052
438 BLOOD CHLORIDE INCREASED 9 0.0052
439 PULMONARY TUBERCULOSIS 22 0.0051
440 BONE MARROW FAILURE 104 0.0051
441 LYMPHOCYTOSIS 11 0.0051
442 HAEMORRHAGE URINARY TRACT 13 0.0051
443 NECROTISING FASCIITIS 18 0.0051
444 INTESTINAL ISCHAEMIA 28 0.0051
445 ENCEPHALITIS 35 0.0051
446 SHOCK HAEMORRHAGIC 41 0.0050
447 HAEMOLYTIC ANAEMIA 45 0.0050
448 DIABETIC NEPHROPATHY 11 0.0050
449 CLOSTRIDIUM TEST POSITIVE 11 0.0050
450 SMALL INTESTINAL HAEMORRHAGE 10 0.0050
451 ENDOCARDITIS 25 0.0049
452 ORGANISING PNEUMONIA 24 0.0048
453 ABDOMINAL ABSCESS 21 0.0047
454 PULMONARY HAEMORRHAGE 37 0.0047
455 HEPATITIS B REACTIVATION 15 0.0047
456 PANCYTOPENIA 264 0.0047
457 RESPIRATORY FAILURE 343 0.0047
458 HEPATOSPLENOMEGALY 12 0.0047
459 HEPATIC FIBROSIS 16 0.0047
460 VENOOCCLUSIVE LIVER DISEASE 23 0.0047
461 HYPERVOLAEMIA 23 0.0046
462 LUNG INFILTRATION 41 0.0046
463 THROMBOCYTOSIS 17 0.0046
464 CLOSTRIDIUM DIFFICILE COLITIS 49 0.0046
465 CONCOMITANT DISEASE PROGRESSION 9 0.0046
466 STAPHYLOCOCCAL BACTERAEMIA 20 0.0046
467 IMMUNE THROMBOCYTOPENIC PURPURA 13 0.0046
468 LACUNAR INFARCTION 11 0.0046
469 MULTI-ORGAN DISORDER 9 0.0046
470 CELL DEATH 9 0.0045
471 DIASTOLIC DYSFUNCTION 14 0.0045
472 HYPOALBUMINAEMIA 35 0.0045
473 SQUAMOUS CELL CARCINOMA OF SKIN 27 0.0045
474 PORTAL VEIN THROMBOSIS 14 0.0043
475 NORMOCHROMIC NORMOCYTIC ANAEMIA 13 0.0043
476 LATENT TUBERCULOSIS 9 0.0043
477 ANGIOPATHY 24 0.0043
478 HYPOVOLAEMIA 25 0.0043
479 ADENOCARCINOMA OF COLON 8 0.0043
480 HIGH DENSITY LIPOPROTEIN DECREASED 14 0.0042
481 PULMONARY MASS 62 0.0042
482 POSTOPERATIVE WOUND INFECTION 28 0.0041
483 ARTERIOSCLEROSIS 39 0.0041
484 SHOCK 95 0.0041
485 ACUTE PULMONARY OEDEMA 23 0.0041
486 ASCITES 120 0.0041
487 WOUND COMPLICATION 14 0.0041
488 HYPERACUSIS 15 0.0040
489 DRUG LEVEL ABOVE THERAPEUTIC 18 0.0039
490 SEPSIS 437 0.0039
491 CLOSTRIDIAL INFECTION 13 0.0038
492 HEART VALVE INCOMPETENCE 11 0.0038
493 VENOUS THROMBOSIS 15 0.0038
494 ESCHERICHIA SEPSIS 11 0.0038
495 CORONARY ARTERY STENOSIS 19 0.0038
496 HAEMOLYSIS 29 0.0038
497 ENCEPHALOPATHY 92 0.0037
498 PANCREATITIS ACUTE 84 0.0037
499 PROTEIN TOTAL DECREASED 14 0.0037
500 METASTATIC NEOPLASM 16 0.0037
501 CATHETER SITE INFECTION 14 0.0037
502 POLYURIA 30 0.0037
503 SUBDURAL HAEMORRHAGE 10 0.0037
504 ACUTE PSYCHOSIS 9 0.0036
505 FUNGAL INFECTION 120 0.0036
506 HYPERLIPIDAEMIA 43 0.0036
507 BLOOD LACTATE DEHYDROGENASE INCREASED 57 0.0036
508 VENTRICULAR HYPERTROPHY 9 0.0036
509 ACUTE HEPATIC FAILURE 49 0.0036
510 DUODENITIS 11 0.0036
511 ILEUS PARALYTIC 16 0.0036
512 FIBROSIS 11 0.0036
513 PORTAL HYPERTENSION 11 0.0036
514 HYPOPHOSPHATAEMIA 26 0.0035
515 FOOD ALLERGY 27 0.0035
516 DUODENAL ULCER HAEMORRHAGE 10 0.0035
517 LUNG INFECTION 54 0.0035
518 WOUND INFECTION 38 0.0035
519 LARGE INTESTINE PERFORATION 24 0.0035
520 TONSILLITIS 18 0.0034
521 APLASTIC ANAEMIA 18 0.0034
522 STAPHYLOCOCCAL SEPSIS 17 0.0034
523 GASTRITIS EROSIVE 16 0.0034
524 GASTROENTERITIS 50 0.0034
525 ONYCHOMYCOSIS 15 0.0034
526 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
527 RENAL TRANSPLANT 12 0.0033
528 HEPATIC FAILURE 100 0.0033
529 NEUROTOXICITY 58 0.0033
530 CACHEXIA 17 0.0033
531 HEPATOCELLULAR CARCINOMA 25 0.0033
532 PROSTATITIS 10 0.0033
533 HYPERKALAEMIA 115 0.0033
534 MULTIPLE-DRUG RESISTANCE 10 0.0032
535 ARTHRITIS BACTERIAL 13 0.0032
536 NON-CARDIAC CHEST PAIN 10 0.0032
537 TYPE 1 DIABETES MELLITUS 19 0.0032
538 COVID-19 PNEUMONIA 37 0.0031
539 SKIN INFECTION 35 0.0031
540 ENTEROCOLITIS 18 0.0031
541 ACUTE RESPIRATORY FAILURE 59 0.0031
542 LUNG NEOPLASM 13 0.0030
543 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
544 ACUTE KIDNEY INJURY 462 0.0030
545 ACUTE CORONARY SYNDROME 25 0.0030
546 END STAGE RENAL DISEASE 55 0.0030
547 NEPHRITIS 10 0.0030
548 DEVICE RELATED INFECTION 46 0.0030
549 AMYLASE INCREASED 11 0.0030
550 ENTERITIS 19 0.0030
551 IRITIS 9 0.0030
552 STAPHYLOCOCCAL INFECTION 97 0.0029
553 HAEMATURIA 100 0.0029
554 VASCULITIS 34 0.0029
555 BRAIN DEATH 9 0.0029
556 NEUTROPENIA 390 0.0029
557 ISCHAEMIA 13 0.0028
558 CHOLESTASIS 54 0.0028
559 HEPATIC ENZYME ABNORMAL 14 0.0028
560 HYPOMAGNESAEMIA 39 0.0028
561 ANAL ABSCESS 15 0.0028
562 HERPES VIRUS INFECTION 16 0.0028
563 NEPHROTIC SYNDROME 19 0.0028
564 PLEURAL EFFUSION 168 0.0028
565 HEPATIC NEOPLASM 9 0.0028
566 PERITONITIS 57 0.0027
567 CANDIDIASIS 11 0.0027
568 THROMBOCYTOPENIA 304 0.0027
569 BRONCHIECTASIS 18 0.0027
570 BASAL CELL CARCINOMA 41 0.0026
571 SKIN LESION 72 0.0026
572 ABDOMINAL TENDERNESS 13 0.0026
573 WHITE BLOOD CELL COUNT INCREASED 100 0.0026
574 BLOOD CREATININE ABNORMAL 9 0.0026
575 ATELECTASIS 25 0.0026
576 PULMONARY CONGESTION 34 0.0026
577 PSYCHIATRIC SYMPTOM 19 0.0026
578 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
579 LUNG TRANSPLANT 9 0.0025
580 RESPIRATORY SYNCYTIAL VIRUS INFECTION 22 0.0025
581 HEMIPLEGIA 21 0.0025
582 COAGULOPATHY 42 0.0025
583 SUBCUTANEOUS ABSCESS 12 0.0025
584 DISEASE RECURRENCE 119 0.0025
585 C-REACTIVE PROTEIN INCREASED 90 0.0025
586 HYPERGLYCAEMIA 90 0.0025
587 LOW DENSITY LIPOPROTEIN INCREASED 19 0.0025
588 SUSPECTED OFF LABEL USE 11 0.0024
589 EXTRAVASATION 10 0.0024
590 BLOOD URIC ACID INCREASED 14 0.0024
591 AGRANULOCYTOSIS 45 0.0024
592 ILEUS 30 0.0024
593 ANAEMIA 457 0.0024
594 HYPERTRIGLYCERIDAEMIA 14 0.0024
595 NEUTROPENIC SEPSIS 17 0.0024
596 TOXIC ENCEPHALOPATHY 12 0.0024
597 GLOMERULAR FILTRATION RATE DECREASED 29 0.0024
598 DIABETES MELLITUS 179 0.0023
599 HAEMATOMA 60 0.0023
600 VIRAL UPPER RESPIRATORY TRACT INFECTION 11 0.0023
601 URINARY TRACT INFECTION 394 0.0023
602 CARDIOPULMONARY FAILURE 9 0.0023
603 WOUND SECRETION 9 0.0023
604 TACHYPNOEA 31 0.0023
605 BLOOD CREATINE INCREASED 10 0.0023
606 ABSCESS 36 0.0023
607 ANAL FISTULA 12 0.0022
608 CARDIOGENIC SHOCK 32 0.0022
609 METABOLIC ACIDOSIS 71 0.0022
610 RENAL FAILURE CHRONIC 17 0.0022
611 PRODUCT USE IN UNAPPROVED INDICATION 542 0.0022
612 ELECTROLYTE IMBALANCE 25 0.0021
613 APPENDICITIS 20 0.0021
614 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
615 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
616 CEREBRAL INFARCTION 52 0.0021
617 HEMIPARESIS 36 0.0021
618 FAILURE TO THRIVE 11 0.0021
619 TOXICITY TO VARIOUS AGENTS 354 0.0021
620 GESTATIONAL DIABETES 10 0.0021
621 GASTROINTESTINAL TOXICITY 10 0.0021
622 HAEMOGLOBIN DECREASED 213 0.0021
623 POST PROCEDURAL HAEMORRHAGE 24 0.0021
624 IMMUNOSUPPRESSION 18 0.0020
625 BLOOD BILIRUBIN INCREASED 55 0.0020
626 LARGE INTESTINE POLYP 14 0.0020
627 CARDIOTOXICITY 18 0.0020
628 CLOSTRIDIUM DIFFICILE INFECTION 44 0.0020
629 HEPATIC FUNCTION ABNORMAL 75 0.0020
630 MOUTH ULCERATION 42 0.0020
631 STATUS EPILEPTICUS 22 0.0019
632 NEPHROGENIC ANAEMIA 9 0.0019
633 PULMONARY OEDEMA 87 0.0019
634 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
635 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
636 DERMATITIS BULLOUS 14 0.0019
637 HYPOTONIA 19 0.0019
638 METABOLIC DISORDER 11 0.0019
639 CEREBRAL DISORDER 14 0.0019
640 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
641 MENTAL STATUS CHANGES 52 0.0019
642 DRUG LEVEL DECREASED 19 0.0019
643 SUBARACHNOID HAEMORRHAGE 19 0.0019
644 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 102 0.0019
645 PAPULE 13 0.0018
646 TRANSAMINASES INCREASED 41 0.0018
647 DUODENAL ULCER 13 0.0018
648 LIPASE INCREASED 14 0.0018
649 RENAL FAILURE ACUTE 77 0.0018
650 DRUG LEVEL BELOW THERAPEUTIC 10 0.0018
651 APHTHOUS ULCER 14 0.0018
652 GASTRIC ULCER HAEMORRHAGE 10 0.0018
653 VENTRICULAR FIBRILLATION 20 0.0018
654 PYREXIA 623 0.0018
655 SPLENOMEGALY 21 0.0018
656 LIVER FUNCTION TEST ABNORMAL 52 0.0018
657 VIRAL INFECTION 59 0.0018
658 METASTASES TO LIVER 31 0.0018
659 MUCOSAL INFLAMMATION 46 0.0018
660 HYPOXIA 61 0.0017
661 FLUID OVERLOAD 25 0.0017
662 OSTEOMYELITIS 31 0.0017
663 RENAL FAILURE 227 0.0017
664 HYPERTHERMIA 13 0.0017
665 CIRCULATORY COLLAPSE 29 0.0017
666 PNEUMOTHORAX 27 0.0017
667 PNEUMONITIS 46 0.0017
668 HEPATITIS 43 0.0017
669 GASTROINTESTINAL INFECTION 15 0.0017
670 ORAL CANDIDIASIS 22 0.0017
671 UPPER RESPIRATORY TRACT INFECTION 77 0.0017
672 HYPERCHOLESTEROLAEMIA 16 0.0017
673 HYDROCEPHALUS 9 0.0017
674 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
675 HYPERBILIRUBINAEMIA 17 0.0016
676 ANAPHYLACTIC SHOCK 42 0.0016
677 CARDIOMEGALY 20 0.0016
678 IRON DEFICIENCY ANAEMIA 15 0.0016
679 DRUG INTERACTION 253 0.0016
680 MYOCARDIAL ISCHAEMIA 18 0.0016
681 GASTRIC ULCER 30 0.0016
682 INFECTION 228 0.0016
683 POST PROCEDURAL COMPLICATION 30 0.0016
684 RESPIRATORY DISTRESS 43 0.0016
685 MYELODYSPLASTIC SYNDROME 22 0.0015
686 MALNUTRITION 17 0.0015
687 CARDIAC ARREST 125 0.0015
688 ORAL DISORDER 11 0.0015
689 ENDOPHTHALMITIS 9 0.0015
690 RENAL INJURY 44 0.0015
691 COLITIS 56 0.0015
692 NERVOUS SYSTEM DISORDER 46 0.0015
693 HAEMORRHAGE INTRACRANIAL 22 0.0015
694 PERICARDIAL EFFUSION 34 0.0015
695 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
696 ACIDOSIS 11 0.0014
697 HYPERTRANSAMINASAEMIA 10 0.0014
698 LEUKOCYTOSIS 26 0.0014
699 HERPES ZOSTER 82 0.0014
700 MITRAL VALVE INCOMPETENCE 16 0.0014
701 HEPATOCELLULAR INJURY 20 0.0014
702 FACIAL PARALYSIS 12 0.0014
703 TORSADE DE POINTES 11 0.0014
704 METASTASES TO LUNG 16 0.0014
705 TRICUSPID VALVE INCOMPETENCE 11 0.0014
706 RESPIRATORY TRACT INFECTION 36 0.0014
707 EOSINOPHILIA 24 0.0014
708 ALANINE AMINOTRANSFERASE INCREASED 84 0.0014
709 ACUTE MYOCARDIAL INFARCTION 40 0.0014
710 MENINGITIS 9 0.0013
711 CYTOKINE RELEASE SYNDROME 27 0.0013
712 DIALYSIS 19 0.0013
713 PROCEDURAL PAIN 37 0.0013
714 ORAL HERPES 26 0.0013
715 PNEUMONIA ASPIRATION 33 0.0013
716 OPTIC NEURITIS 12 0.0013
717 HAEMATOCRIT DECREASED 26 0.0013
718 DRUG-INDUCED LIVER INJURY 41 0.0013
719 RASH MACULO-PAPULAR 29 0.0013
720 GRAND MAL CONVULSION 12 0.0013
721 RIGHT VENTRICULAR FAILURE 9 0.0013
722 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
723 MALIGNANT MELANOMA 17 0.0013
724 RENAL CYST 10 0.0013
725 GASTROINTESTINAL HAEMORRHAGE 105 0.0013
726 INTESTINAL PERFORATION 14 0.0012
727 BLOOD CALCIUM DECREASED 14 0.0012
728 PNEUMONIA 403 0.0012
729 OFF LABEL USE 1081 0.0012
730 BODY TEMPERATURE INCREASED 25 0.0012
731 HEPATOMEGALY 12 0.0012
732 SMALL INTESTINAL OBSTRUCTION 15 0.0012
733 PREMATURE DELIVERY 19 0.0012
734 PERITONITIS BACTERIAL 12 0.0012
735 AORTIC ANEURYSM 9 0.0012
736 HEPATIC ENCEPHALOPATHY 11 0.0012
737 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
738 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
739 SKIN CANCER 25 0.0012
740 APHASIA 35 0.0012
741 CARDIAC FAILURE 93 0.0012
742 LYMPHADENOPATHY 41 0.0012
743 METASTASES TO BONE 19 0.0012
744 PLATELET COUNT DECREASED 123 0.0012
745 PLASMA CELL MYELOMA 45 0.0012
746 COVID-19 201 0.0011
747 LIVER INJURY 28 0.0011
748 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
749 SINUS TACHYCARDIA 16 0.0011
750 HYPOKALAEMIA 52 0.0011
751 SENSORY LOSS 9 0.0011
752 CELLULITIS 56 0.0011
753 MYELOSUPPRESSION 40 0.0011
754 OEDEMA 60 0.0011
755 DRUG TOXICITY 15 0.0011
756 LYMPHOMA 17 0.0011
757 IMPAIRED HEALING 36 0.0011
758 CEREBRAL HAEMORRHAGE 39 0.0011
759 PANCREATITIS 57 0.0011
760 MASS 15 0.0011
761 DELIRIUM 37 0.0011
762 FOLLICULITIS 11 0.0010
763 INFLAMMATION 54 0.0010
764 HEPATOTOXICITY 23 0.0010
765 ASPARTATE AMINOTRANSFERASE INCREASED 54 0.0010
766 DEEP VEIN THROMBOSIS 66 0.0010
767 HYPOCALCAEMIA 19 0.0010
768 HYPERTENSION 211 0.0010
769 HALLUCINATION, VISUAL 21 0.0010
770 GASTROINTESTINAL DISORDER 89 0.0010
771 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
772 RENAL DISORDER 46 0.0010
773 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
774 JAUNDICE 26 0.0010
775 TREATMENT FAILURE 80 0.0010
776 DEFORMITY 9 0.0010
777 DIARRHOEA HAEMORRHAGIC 9 0.0010
778 FLANK PAIN 9 0.0010
779 DYSURIA 35 0.0009
780 BLOOD URINE PRESENT 18 0.0009
781 GASTROENTERITIS VIRAL 17 0.0009
782 URINARY RETENTION 31 0.0009
783 HIATUS HERNIA 12 0.0009
784 OESOPHAGITIS 10 0.0009
785 ABDOMINAL PAIN 212 0.0009
786 OEDEMA PERIPHERAL 111 0.0009
787 HEPATIC CIRRHOSIS 17 0.0009
788 INTESTINAL OBSTRUCTION 34 0.0009
789 INTENTIONAL PRODUCT USE ISSUE 78 0.0009
790 GENERALISED OEDEMA 11 0.0009
791 COMA 42 0.0009
792 CHRONIC KIDNEY DISEASE 67 0.0009
793 IMPAIRED GASTRIC EMPTYING 12 0.0009
794 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
795 ATRIAL FIBRILLATION 85 0.0009
796 TACHYCARDIA 77 0.0009
797 HEPATIC STEATOSIS 16 0.0009
798 ATAXIA 10 0.0008
799 PARALYSIS 12 0.0008
800 GASTRITIS 22 0.0008
801 HYPOTENSION 167 0.0008
802 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
803 MELAENA 18 0.0008
804 EPILEPSY 25 0.0008
805 FEBRILE NEUTROPENIA 54 0.0008
806 HYPERCALCAEMIA 10 0.0008
807 DIARRHOEA 520 0.0008
808 BLOOD POTASSIUM INCREASED 13 0.0008
809 HYPONATRAEMIA 45 0.0008
810 CHOLELITHIASIS 26 0.0008
811 HEPATIC ENZYME INCREASED 54 0.0008
812 ABDOMINAL PAIN LOWER 20 0.0008
813 HAEMORRHAGE 80 0.0008
814 CHOLECYSTITIS 9 0.0008
815 LACTIC ACIDOSIS 24 0.0007
816 UVEITIS 10 0.0007
817 THERAPY NON-RESPONDER 33 0.0007
818 INTERSTITIAL LUNG DISEASE 35 0.0007
819 TOOTH DISORDER 16 0.0007
820 ARRHYTHMIA 34 0.0007
821 RASH PAPULAR 16 0.0007
822 PRODUCTIVE COUGH 34 0.0007
823 HEPATIC CYTOLYSIS 9 0.0007
824 SEIZURE 81 0.0007
825 RED BLOOD CELL COUNT DECREASED 20 0.0007
826 ABDOMINAL DISTENSION 73 0.0007
827 DRUG INEFFECTIVE 918 0.0007
828 FAECES DISCOLOURED 15 0.0007
829 RASH ERYTHEMATOUS 33 0.0007
830 PULMONARY EMBOLISM 65 0.0007
831 HAEMOPTYSIS 19 0.0007
832 LIVER DISORDER 30 0.0007
833 IMMUNODEFICIENCY 10 0.0007
834 BLOOD PRESSURE FLUCTUATION 16 0.0007
835 DEHYDRATION 88 0.0007
836 ADRENAL INSUFFICIENCY 8 0.0007
837 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
838 LUNG DISORDER 32 0.0007
839 DISEASE PROGRESSION 77 0.0007
840 CARDIO-RESPIRATORY ARREST 27 0.0006
841 SUBDURAL HAEMATOMA 9 0.0006
842 ANGINA PECTORIS 18 0.0006
843 PULMONARY FIBROSIS 12 0.0006
844 BLOOD GLUCOSE INCREASED 116 0.0006
845 GENERAL PHYSICAL HEALTH DETERIORATION 71 0.0006
846 DYSARTHRIA 23 0.0006
847 CARDIOMYOPATHY 9 0.0006
848 TREATMENT NONCOMPLIANCE 33 0.0006
849 BLOOD CHOLESTEROL INCREASED 28 0.0006
850 ANAPHYLACTIC REACTION 33 0.0006
851 CONVULSION 34 0.0006
852 TENDONITIS 9 0.0006
853 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
854 SKIN ULCER 15 0.0006
855 THERAPY PARTIAL RESPONDER 9 0.0006
856 RESPIRATORY DISORDER 17 0.0006
857 PREMATURE BABY 17 0.0006
858 KIDNEY INFECTION 11 0.0006
859 TREMOR 93 0.0006
860 DRUG INTOLERANCE 53 0.0005
861 PRODUCT USE ISSUE 103 0.0005
862 OSTEONECROSIS 18 0.0005
863 BLOOD SODIUM DECREASED 10 0.0005
864 DISORIENTATION 21 0.0005
865 BLOOD PRESSURE DECREASED 35 0.0005
866 HAEMATOCHEZIA 29 0.0005
867 THROMBOSIS 42 0.0005
868 OXYGEN SATURATION DECREASED 29 0.0005
869 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
870 CARDIOVASCULAR DISORDER 13 0.0005
871 OSTEOPOROSIS 21 0.0005
872 ISCHAEMIC STROKE 9 0.0005
873 NEOPLASM MALIGNANT 33 0.0005
874 NEUTROPHIL COUNT DECREASED 20 0.0005
875 CONFUSIONAL STATE 79 0.0005
876 CHEST DISCOMFORT 50 0.0005
877 POLLAKIURIA 20 0.0005
878 THERAPEUTIC RESPONSE DECREASED 29 0.0005
879 DYSPNOEA EXERTIONAL 18 0.0005
880 RESPIRATORY ARREST 13 0.0005
881 HYPOPHAGIA 12 0.0005
882 HAEMORRHOIDS 9 0.0005
883 CONDITION AGGRAVATED 138 0.0005
884 CHILLS 51 0.0004
885 BRADYCARDIA 22 0.0004
886 VOMITING 194 0.0004
887 INFLUENZA 46 0.0004
888 NEUROPATHY PERIPHERAL 39 0.0004
889 MATERNAL EXPOSURE DURING PREGNANCY 36 0.0004
890 CORONARY ARTERY DISEASE 12 0.0004
891 GASTRIC CANCER 10 0.0004
892 MENTAL DISORDER 17 0.0004
893 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
894 MUSCULOSKELETAL PAIN 20 0.0004
895 CYSTITIS 12 0.0004
896 DIABETIC KETOACIDOSIS 9 0.0004
897 URINARY INCONTINENCE 11 0.0004
898 EXPOSURE DURING PREGNANCY 23 0.0004
899 PALLOR 10 0.0004
900 BLOOD POTASSIUM DECREASED 11 0.0004
901 SURGERY 21 0.0004
902 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
903 DECREASED APPETITE 81 0.0003
904 BLINDNESS 14 0.0003
905 LOSS OF CONSCIOUSNESS 44 0.0003
906 LUNG NEOPLASM MALIGNANT 14 0.0003
907 PSYCHOTIC DISORDER 10 0.0003
908 FLUID RETENTION 17 0.0003
909 STOMATITIS 20 0.0003
910 DIVERTICULITIS 9 0.0003
911 MUSCULAR WEAKNESS 36 0.0003
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
913 DYSPNOEA 174 0.0003
914 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
915 BLOOD PRESSURE INCREASED 45 0.0003
916 RHABDOMYOLYSIS 12 0.0003
917 OVERDOSE 62 0.0003
918 NEPHROLITHIASIS 13 0.0003
919 COGNITIVE DISORDER 13 0.0003
920 COUGH 78 0.0003
921 ASTHENIA 102 0.0003
922 TYPE 2 DIABETES MELLITUS 9 0.0003
923 WEIGHT DECREASED 69 0.0002
924 VERTIGO 15 0.0002
925 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
926 LETHARGY 14 0.0002
927 CONSTIPATION 53 0.0002
928 DYSPHAGIA 23 0.0002
929 INFUSION RELATED REACTION 16 0.0002
930 PRODUCT STORAGE ERROR 21 0.0002
931 NAUSEA 186 0.0002
932 ERYTHEMA 48 0.0002
933 WEIGHT INCREASED 52 0.0002
934 BLISTER 13 0.0002
935 BRONCHITIS 17 0.0002
936 MALAISE 100 0.0002
937 VISUAL IMPAIRMENT 28 0.0002
938 ABORTION SPONTANEOUS 9 0.0002
939 CHEST PAIN 39 0.0002
940 RENAL CANCER 10 0.0002
941 HYPOGLYCAEMIA 10 0.0002
942 SINUSITIS 21 0.0002
943 AGITATION 15 0.0002
944 SOMNOLENCE 39 0.0002
945 ECZEMA 10 0.0002
946 FLUSHING 19 0.0002
947 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
948 CATARACT 11 0.0002
949 ABDOMINAL PAIN UPPER 38 0.0002
950 HEADACHE 115 0.0002
951 SWELLING 17 0.0002
952 ALOPECIA 35 0.0002
953 BACK PAIN 41 0.0002
954 EPISTAXIS 13 0.0002
955 SYNCOPE 17 0.0002
956 WHEEZING 10 0.0002
957 DEATH 145 0.0002
958 MYALGIA 28 0.0002
959 MYOCARDIAL INFARCTION 28 0.0002
960 EYE PAIN 9 0.0002
961 RASH 68 0.0002
962 PALPITATIONS 18 0.0002
963 ARTHRITIS 12 0.0002
964 HEART RATE INCREASED 15 0.0002
965 OROPHARYNGEAL PAIN 14 0.0002
966 PERIPHERAL SWELLING 23 0.0001
967 ABDOMINAL DISCOMFORT 24 0.0001
968 SLEEP DISORDER 10 0.0001
969 PARAESTHESIA 22 0.0001
970 CARDIAC FAILURE CONGESTIVE 11 0.0001
971 NASOPHARYNGITIS 24 0.0001
972 CEREBROVASCULAR ACCIDENT 22 0.0001
973 PAIN IN EXTREMITY 38 0.0001
974 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
975 ARTHRALGIA 52 0.0001
976 ADVERSE DRUG REACTION 11 0.0001
977 DYSPEPSIA 11 0.0001
978 VISION BLURRED 15 0.0001
979 ACNE 8 0.0001
980 GAIT DISTURBANCE 19 0.0001
981 FATIGUE 77 0.0001
982 PAIN 59 0.0001
983 NO ADVERSE EVENT 16 0.0001
984 HYPOAESTHESIA 13 0.0001
985 PRURITUS 30 0.0001
986 MEMORY IMPAIRMENT 10 0.0001
987 HYPERSENSITIVITY 13 0.0001
988 PSORIASIS 9 0.0001
989 DIZZINESS 31 0.0001
990 DEPRESSION 13 0.0001
991 FALL 19 0.0001
992 INSOMNIA 15 0.0001
993 URTICARIA 9 0.0001